Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA

DOI: 10.1080/2162402X.2016.1138199

Keywords: B-cell malignancies, CD20, gene therapy, haploidentical allogeneic stem cell transplantation, immunotherapy, T-cell receptor

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text